US 7786290
Double-stranded ribonucleic acid with increased effectiveness in an organism
granted A61PA61P35/00A61P37/00
Quick answer
US patent 7786290 (Double-stranded ribonucleic acid with increased effectiveness in an organism) held by Alnylam Pharmaceuticals, Inc. expires Mon Aug 26 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Alnylam Pharmaceuticals, Inc.
- Grant date
- Tue Aug 31 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 26 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 31
- CPC classes
- A61P, A61P35/00, A61P37/00, A61P5/00, A61P7/00